Immunogenicity 5
Sample ID
A005
Response
Negative
Tumor Type
Endometrial cancer
Gene Symbol
KRAS
Transcript ID
None
HLA INFO
C*03:03
TCR INFO
No TCR info found!
Full length protein sequence (189 aa)
MTEYK
1
LVVVG
6
AGGVG
11
KSALT
16
IQLIQ
21
NHFVD
26
EYDPT
31
IEDSY
36
RKQVV
41
IDGET
46
CLLDI
51
LDTAG
56
QEEYS
61
AMRDQ
66
YMRTG
71
EGFLC
76
VFAIN
81
NTKSF
86
EDIHH
91
YREQI
96
KRVKD
101
SEDVP
106
MVLVG
111
NKCDL
116
PSRTV
121
DTKQA
126
QDLAR
131
SYGIP
136
FIETS
141
AKTRQ
146
RVEDA
151
FYTLV
156
REIRQ
161
YRLKK
166
ISKEE
171
KTPGC
176
VKIKK
181
CIIM
186
Mutation Information
DNA mutation:
None
Peptide Range:
8 ~ 16
Mut AA position:
12 (5 in Wild Type peptide)
Alignment
Wild Type:
"VVGAGGVGK
||||.||||
Mutant:
VVGACGVGK"
J Clin Invest, 2019
Neoantigen identification strategies enable personalized immunotherapy in refractory solid tumorsGene Name (from Reference) KRAS
Checkpoint
Blockade
None
ACT
N
Vaccination
N
Curative
Effect
N
minimal_peptide
VVGACGVGK
Antigen
Type
peptide
T-cell
Source
PBMCs
APC
Type
DSs
Assay
ELISPOT